NCT05827198View on ClinicalTrials.gov

Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Candies

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 12, 2023

Primary Completion Date

December 22, 2023

Study Completion Date

January 27, 2024

Conditions
Gastrointestinal ToleranceHealthy Population
Interventions
OTHER

Low-sugar candies compared to regular sugar candies

Acute intake

Trial Locations (1)

Unknown

Inquis Clinical Research, Toronto

Sponsors

Collaborators (1)

INQUIS Clinical Research
All Listed Sponsors
collaborator

INQUIS Clinical Research

INDUSTRY

lead

Mondelēz International, Inc.

INDUSTRY